SS
KPRX icon

SBI Securities’s Kiora Pharmaceuticals KPRX Stock Holding History

SBI Securities’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$673 Hold
256
– – ﹤0.01% 2934
2026
Q1 		$494 Hold
256
– – ﹤0.01% 2897
2025
Q4 		$504 Hold
256
– – ﹤0.01% 2878
2025
Q3 		$712 Hold
256
– – ﹤0.01% 2828
2025
Q2 		$737 Hold
256
– – ﹤0.01% 2809
2025
Q1 		$771 Buy
256
+255
+25,500% +$885 ﹤0.01% 2696
2024
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 4038

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

SBI Securities's KPRX Position: Q2 2026 in Review

SBI Securities held its Kiora Pharmaceuticals (KPRX) position steady in Q2 2026 at 256 shares worth $673. The position accounts for ﹤0.01% of the portfolio, ranked #2934.

SBI Securities first reported a position in KPRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $771 in Q1 2025. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • SBI Securities held 256 shares of Kiora Pharmaceuticals worth $673 as of Q2 2026.
  • SBI Securities left its Kiora Pharmaceuticals share count unchanged in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2934 holding.
  • SBI Securities first reported a position in Kiora Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Kiora Pharmaceuticals position peaked at $771 in Q1 2025.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.